Filing Details
- Accession Number:
- 0001562180-19-002783
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-13 19:40:21
- Reporting Period:
- 2019-05-09
- Accepted Time:
- 2019-05-13 19:40:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1603756 | Axonics Modulation Technologies Inc. | AXNX | Surgical & Medical Instruments & Apparatus (3841) | 454744083 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1756399 | Rinda Sama | 26 Technology Drive Irvine CA 92618 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-05-09 | 871 | $1.42 | 4,871 | No | 4 | M | Indirect | By Spouse |
Common Stock | Acquisiton | 2019-05-09 | 1,225 | $1.63 | 6,096 | No | 4 | M | Indirect | By Spouse |
Common Stock | Acquisiton | 2019-05-09 | 941 | $1.32 | 7,037 | No | 4 | M | Indirect | By Spouse |
Common Stock | Acquisiton | 2019-05-09 | 480 | $1.32 | 7,517 | No | 4 | M | Indirect | By Spouse |
Common Stock | Acquisiton | 2019-05-09 | 6,228 | $0.98 | 13,745 | No | 4 | M | Indirect | By Spouse |
Common Stock | Acquisiton | 2019-05-09 | 1,800 | $0.97 | 15,545 | No | 4 | M | Indirect | By Spouse |
Common Stock | Acquisiton | 2019-05-09 | 1,800 | $0.97 | 17,345 | No | 4 | M | Indirect | By Spouse |
Common Stock | Disposition | 2019-05-09 | 13,345 | $28.03 | 4,000 | No | 4 | S | Indirect | By Spouse |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Indirect | By Spouse |
No | 4 | M | Indirect | By Spouse |
No | 4 | M | Indirect | By Spouse |
No | 4 | M | Indirect | By Spouse |
No | 4 | M | Indirect | By Spouse |
No | 4 | M | Indirect | By Spouse |
No | 4 | M | Indirect | By Spouse |
No | 4 | S | Indirect | By Spouse |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to buy) | Disposition | 2019-05-09 | 871 | $0.00 | 871 | $1.42 |
Common Stock | Stock Options (Right to buy) | Disposition | 2019-05-09 | 1,225 | $0.00 | 1,225 | $1.63 |
Common Stock | Stock Options (Right to buy) | Disposition | 2019-05-09 | 941 | $0.00 | 941 | $1.32 |
Common Stock | Stock Options (Right to buy) | Disposition | 2019-05-09 | 480 | $0.00 | 480 | $1.32 |
Common Stock | Stock Options (Right to buy) | Disposition | 2019-05-09 | 6,228 | $0.00 | 6,228 | $0.98 |
Common Stock | Stock Options (Right to buy) | Disposition | 2019-05-09 | 1,800 | $0.00 | 1,800 | $0.97 |
Common Stock | Stock Options (Right to buy) | Disposition | 2019-05-09 | 1,800 | $0.00 | 1,800 | $0.97 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
1,021 | 2027-08-25 | No | 4 | M | Indirect | |
2,975 | 2028-03-30 | No | 4 | M | Indirect | |
929 | 2027-05-22 | No | 4 | M | Indirect | |
560 | 2027-07-05 | No | 4 | M | Indirect | |
1,244 | 2026-01-15 | No | 4 | M | Indirect | |
0 | 2024-06-29 | No | 4 | M | Indirect | |
0 | 2025-04-01 | No | 4 | M | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 220,627 | Direct |
Footnotes
- The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.91 to $28.17, inclusive. The reporting person undertakes to provide Axonics Modulation Technologies, Inc., any security holder of Axonics Modulation Technologies, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on July 21, 2018 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of July 21, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
- The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on March 30, 2019 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of March 30, 2019, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
- The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on May 23, 2018 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of May 23, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
- The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on July 5, 2017 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of July 5, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
- The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on January 15, 2017 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of January 15, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
- he shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on June 30, 2015 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of June 30, 2015, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
- The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on April 2, 2016 and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of April 2, 2016, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.